Connection
Michael Clay to Rhabdomyosarcoma, Embryonal
This is a "connection" page, showing publications Michael Clay has written about Rhabdomyosarcoma, Embryonal.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.202 |
|
|
|
-
Patel AG, Chen X, Huang X, Clay MR, Komorova N, Krasin MJ, Pappo A, Tillman H, Orr BA, McEvoy J, Gordon B, Blankenship K, Reilly C, Zhou X, Norrie JL, Karlstrom A, Yu J, Wodarz D, Stewart E, Dyer MA. The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma. Dev Cell. 2022 05 23; 57(10):1226-1240.e8.
Score: 0.202